Las Vegas, NV -- (SBWIRE) -- 12/18/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.EquityObserver.com issues a special report on the following stocks: New Residential Investment Corp(NYSE:NRZ), Inovio Pharmaceuticals Inc(NYSEMKT:INO), Omeros Corporation(NASDAQ:OMER), Integrated Device Technology Inc(NASDAQ:IDTI)
New Residential Investment Corp(NYSE:NRZ) increased 3.57% at the price of $6.68 recently on a traded volume of 2.31million shares, in comparison to 2.85 million shares of average trading volume. So far this year, the stock is up over 5.05%.
The company has a total market capitalization of $1.69 million and its total outstanding shares are 253.19 million. New Residential Investment Corp., incorporated on September 26, 2013, is a real estate investment trust. The Company focuses on investing in, and actively managing, investments related to residential real estate. The Company is managed by an affiliate of Fortress Investment Group LLC, a global investment management.
For How Long NRZ will Fight for Profitability? Read This Trend Analysis report
Inovio Pharmaceuticals Inc(NYSEMKT:INO) soared 1.90% at the trading price of $2.15 on a traded volume of 2.43 million shares till now, whereas its average trading volume is 2.60 million shares. In the last three months, the stock is down -8.9%. The Intra-day range for the stock is $2.11 and $2.20. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens
For How Long INO Gloss will Attract Investors? Find out via this report
Omeros Corporation(NASDAQ:OMER) jumped up 10.31% at the $9.84 recently. So far in three months, the stock is up 18.79%. The 52-week range for the stock is $9.42 and $10.33. Its introductory price for the day was $9.84, with the overall traded volume of 1.89 million shares. Omeros Corporation operates as a biopharmaceutical company focused on the discovery, development and commercialization of products focused on inflammation and disorders of the central nervous system. The Company develops pharmaceutical and therapeutic approaches to the management of surgical pain and inflammation.
Will OMER Continue To Move Higher? Find Out Here
Integrated Device Technology Inc(NASDAQ:IDTI) after opening its shares at the price of $10.16, dropped -5.49% , its recent trading price was $9.81 for the day. The stock moved on a traded volume of 2.44 million shares, in comparison to 1.34 million shares of average trading volume. Integrated Device Technology, Inc. (IDT) designs, develops, manufactures and markets a broad range of low-power mixed signal semiconductor solutions for the advanced communications, computing and consumer industries. The Company operates in the Communications segment and the Computing and Consumer segment.
Will IDTI Get Buyers Even After The Recent Rally?Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)